Mar 23, 2010 - PositiveID Corporation (NASDAQ: PSID) announced that it has filed with the U.S. Patent and Trademark Office a non-provisional patent application for its iGlucose system, currently under development, which uses wireless SMS messaging to automatically communicate a diabetic patient's blood glucose levels from any data-capable glucose meter to an online database.The iGlucose system is designed to communicate automatically with a wide variety of glucometers by utilizing electronics and stored information that will query and recognize a particular glucometer when connected to the device. This recognition aspect is unique because there are differences in how data is retrieved from different meters and manufacturers.
The iGlucose system also successfully addresses obstacles in SMS data transmission. Blood glucose and other data must be packed into a buffer to make most efficient use of the available bits, since SMS text messages are limited to 140 characters in a single message. Due to SMS transmission limitations, iGlucose utilizes proprietary data compression software and encryption algorithms to overcome these challenges... PositiveID's Press Release -
